Revisiting the markers interleukin-6 and glucagon-like peptide-1 for targeting low-grade inflammation in type 2 diabetes: a meta-analysis and our lab experience.
重新探討白介素-6和胰高血糖素樣肽-1作為針對2型糖尿病低度炎症的標記物:一項綜合分析及我們的實驗室經驗。
Acta Diabetol 2024-10-30
Screening for Inflammatory Markers Identifies IL-18Rα as a Potential Link between Exenatide and Its Anti-Inflammatory Effect: New Results from the Combat-JUDO Randomized Controlled Trial.
透過炎症標誌物篩檢,識別 IL-18Rα 作為 Exenatide 與其抗炎效應之潛在關聯:來自 Combat-JUDO 隨機對照試驗的新結果。
Ann Nutr Metab 2024-01-17
GLP-1 RAs and SGLT2i: two antidiabetic agents associated with immune and inflammation modulatory properties through the common AMPK pathway.
GLP-1 RAs和SGLT2i:兩種與免疫和發炎調節特性相關的抗糖尿病藥物,透過共同的AMPK途徑。
Front Immunol 2024-03-15
The Role of GLP-1, GIP, MCP-1 and IGFBP-7 Biomarkers in the Development of Metabolic Disorders: A Review and Predictive Analysis in the Context of Diabetes and Obesity.
GLP-1、GIP、MCP-1和IGFBP-7生物標誌物在代謝紊亂發展中的角色:糖尿病和肥胖背景下的回顧和預測分析。
Biomedicines 2024-01-28
Impact of Glucagon-Like Peptide 1 Receptor Agonists on Biochemical Markers of the Initiation of Atherosclerotic Process.
GLP-1受體激動劑對動脈粥樣硬化過程啟動的生化標誌的影響。
Int J Mol Sci 2024-02-28
Meta-analysis on GLP-1 mediated modulation of autophagy in islet β-cells: Prospectus for improved wound healing in type 2 diabetes.
GLP-1介導的自噬在胰島β細胞中的荟萃分析:改善第2型糖尿病傷口癒合的前景。
Int Wound J 2024-03-25
Adiponectin may play a crucial role in the metabolic effects of GLP-1RAs treatment in patients with Type 2 Diabetes Mellitus: a preliminary longitudinal study.
Adiponectin 可能在 2 型糖尿病患者接受 GLP-1RAs 治療的代謝效應中扮演關鍵角色:一項初步的縱向研究。
Endocrine 2024-11-09
Human subjects with impaired beta-cell function and glucose tolerance have higher levels of intra-islet intact GLP-1.
人類受試者在胰島素細胞功能和葡萄糖耐受性受損的情況下,具有較高水平的胰島內完整 GLP-1。
Metabolism 2024-12-03
Plasma Glucagon-Like Peptide-1 Levels in Nigerians with Newly Diagnosed Type 2 Diabetes Mellitus: A Cross-Sectional Study.
尼日利亞新診斷的第二型糖尿病患者血漿胰高血糖素樣肽-1水平:一項橫斷面研究。
West Afr J Med 2025-02-26